Targ-Allerg I-101

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NameTarg-Allerg I-101
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin 13 receptor inhibitors
TargetsInterleukin 13 receptor
Therapy Area/IndicationsAsthmaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTargepeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTargepeutics
Active IndicationsN/A
Inactive IndicationsAsthmaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A